A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0614

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen ; volume:105 ; number:12 ; day:15 ; month:6 ; year:2021 ; pages:4957-4973 ; date:6.2021
Applied microbiology and biotechnology ; 105, Heft 12 (15.6.2021), 4957-4973, 6.2021

Creator: Kubickova, Barbara
Schenk, Jörg A.
Ramm, Franziska
Markuškienė, Kornelija
Reetz, Jochen
Dremsek, Paul
Tamosiunas, Paulius Lukas
Cepulyte, Laima
Trinh, Hoai Anh
Scholz, Johannes
Memczak, Henry
Hovestädt, Marc
Ryll, René
Petraityte-Burneikiene, Rasa
Corman, Victor M.
Andersson, Anika
Becher, Dietmar
Groschup, Martin H.
Kubick, Stefan
Sellrie, Frank
Johne, Reimar
Ulrich, Rainer G.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00253-021-11342-7

URN: urn:nbn:de:101:1-2021101006231040765666

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.09.2026, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kubickova, Barbara
Schenk, Jörg A.
Ramm, Franziska
Markuškienė, Kornelija
Reetz, Jochen
Dremsek, Paul
Tamosiunas, Paulius Lukas
Cepulyte, Laima
Trinh, Hoai Anh
Scholz, Johannes
Memczak, Henry
Hovestädt, Marc
Ryll, René
Petraityte-Burneikiene, Rasa
Corman, Victor M.
Andersson, Anika
Becher, Dietmar
Groschup, Martin H.
Kubick, Stefan
Sellrie, Frank
Johne, Reimar
Ulrich, Rainer G.
SpringerLink (Online service)

Other Objects (12)

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments

Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Plasmonic Cross‐Reactive Sensing Noses and Tongues

An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments

Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Plasmonic Cross‐Reactive Sensing Noses and Tongues

An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments

Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Plasmonic Cross‐Reactive Sensing Noses and Tongues

An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments

Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Plasmonic Cross‐Reactive Sensing Noses and Tongues

An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments

Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Plasmonic Cross‐Reactive Sensing Noses and Tongues

An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk

Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments

Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Plasmonic Cross‐Reactive Sensing Noses and Tongues

An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update

Related objects

Reset password